MEPs shun cancer advocacy group because of industry fundingBMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39566.553889.DB (Published 01 May 2008) Cite this as: BMJ 2008;336:980
- Ned Stafford
A group of members of the European parliament with a special interest in breast cancer has cut its ties with a breast cancer advocacy group, Europa Donna, because of the group’s acceptance of financial support from drug companies.
Karin Jöns, chairman of the European parliamentary group on breast cancer (EPGBC), issued a press release last week announcing the decision, saying that 86% of Europa Donna’s income of about €424 000 (£330 000; $660 000) in 2007 came from the industry.
“We at EPGBC reject further cooperation with Europa …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial